Evidence map›Paper›PMID 30012703›Full record

ReviewCirculation2018

Deciphering the Role of Lipid Droplets in Cardiovascular Disease: A Report From the 2017 National Heart, Lung, and Blood Institute Workshop.

Ira J Goldberg, Karen Reue, Nada A Abumrad, Perry E Bickel, Sarah Cohen, Edward A Fisher, Zorina S Galis, James G Granneman, E Douglas Lewandowski, Robert Murphy and 6 more

Open access · greenAbstract readReview
In one paragraph

Review in Circulation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 156 citations in OpenAlex.

  1. Article
  2. Lipid droplets and major metabolic disorders.Molecular biology reports · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. ATGL regulates renal fibrosis by reprogramming lipid metabolism during the transition from AKI to CKD.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 2 countries.

Ira J GoldbergNew York University, New York City (I.J.G., E.A.F.).
Karen ReueUniversity of California, Los Angeles (K.R.).
Nada A AbumradWashington University in St. Louis, MO (N.A.A., J.E.S.).
Perry E BickelUniversity of Texas Southwestern Medical Center, Dallas (P.E.B.).
Sarah CohenUniversity of North Carolina at Chapel Hill (S.C.).
Edward A FisherNew York University, New York City (I.J.G., E.A.F.).
Zorina S GalisNational Institutes of Health/National, Heart, Lung, and Blood Institute, Bethesda, MD (Z.S.G., M.O., L.S.-L., J.C.).
James G GrannemanWayne State University, Detroit, MI (J.G.G.).
E Douglas LewandowskiThe Ohio State University Wexner Medical Center, Columbus (E.D.L.).
Robert MurphyUniversity of Colorado Denver (R.M.).
Michelle OliveNational Institutes of Health/National, Heart, Lung, and Blood Institute, Bethesda, MD (Z.S.G., M.O., L.S.-L., J.C.).
Jean E SchafferWashington University in St. Louis, MO (N.A.A., J.E.S.).
Lisa Schwartz-LongacreNational Institutes of Health/National, Heart, Lung, and Blood Institute, Bethesda, MD (Z.S.G., M.O., L.S.-L., J.C.).
Gerald I ShulmanYale University, Howard Hughes Medical Institute, New Haven, CT (G.I.S.).
Tobias C WaltherHarvard University, Howard Hughes Medical Institute, Boston, MA (T.C.W.).
Jue ChenNational Institutes of Health/National, Heart, Lung, and Blood Institute, Bethesda, MD (Z.S.G., M.O., L.S.-L., J.C.). jue.chen@nih.gov.
National Heart Lung and Blood Institute · USCity University of New York · USHoward Hughes Medical Institute · USWashington University in St. Louis · USThe Ohio State University Wexner Medical Center · USThe University of Texas Southwestern Medical Center · USUniversity of California, Los Angeles · USUniversity of Denver · USUniversity of North Carolina at Chapel Hill · USWayne State University · US

Funding

Systems genomics of metabolic syndrome traitsP01HL028481 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LUSIS, ALDONS JAKE · 1985 to 2019
$50.2M
Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Kevan C Herold, GERALD I SHULMAN · 1993 to 2026
$44.0M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Role of Serum Amyloid A in Diabetic Vascular DiseaseP01HL092969 · NHLBI · UNIVERSITY OF WASHINGTON · PI BORNFELDT, KARIN E. · 2008 to 2019
$23.5M
The Lipin Protein Family and Triglyceride Metabolism P01HL090553 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YOUNG, STEPHEN G. · 2008 to 2018
$23.3M
Molecular Regulation of Atherosclerosis Regression - RenewalR01HL084312 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI FISHER, EDWARD A · 2006 to 2024
$11.4M
CD36 AND INTESTINAL FAT ABSORPTIONR01DK060022 · NIDDK · WASHINGTON UNIVERSITY · PI ABUMRAD, NADA A. · 2001 to 2021
$7.7M
Analysis of Lipolytic Trafficking in Adipocytes.R01DK076629 · NIDDK · WAYNE STATE UNIVERSITY · PI James G Granneman, Christopher V Kelly · 2009 to 2026
$7.1M
Pathways of Tissue Lipid UptakeR01HL045095 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ABUMRAD, NADA A., GOLDBERG, IRA J · 1991 to 2024
$6.9M
Mechanisms of Fatty Acid Uptake By Cardiac MuscleR01HL073029 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GOLDBERG, IRA J · 2003 to 2021
$6.8M
CELLULAR MECHANISMS THAT PROMOTE OR PREVENT LIPOTOXICITYR01DK064989 · NIDDK · WASHINGTON UNIVERSITY · PI SCHAFFER, JEAN E. · 2003 to 2021
$5.8M
FATTY ACID TRANSPORTER: REGULATION, IDENTIFICATIONR01DK033301 · NIDDK · WASHINGTON UNIVERSITY · PI ABUMRAD, NADA A. · 1986 to 2017
$5.2M
Howard Hughes Medical InstituteNHLBI NIH HHS P01 HL028481NHLBI NIH HHS P01 HL090553NHLBI NIH HHS P01 HL092969NHLBI NIH HHS R01 HL045095NHLBI NIH HHS R01 HL049244NHLBI NIH HHS R01 HL056178NHLBI NIH HHS R01 HL062702NHLBI NIH HHS R01 HL073029NHLBI NIH HHS R01 HL084312NHLBI NIH HHS R01 HL113057NHLBI NIH HHS R01 HL127649NHLBI NIH HHS R01 HL127930NHLBI NIH HHS R01 HL129433NHLBI NIH HHS R01 HL132525NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK045735NIDDK NIH HHS R01 DK033301NIDDK NIH HHS R01 DK040936NIDDK NIH HHS R01 DK060022NIDDK NIH HHS R01 DK064989NIDDK NIH HHS R01 DK076629NIDDK NIH HHS R01 DK105963NIDDK NIH HHS R01 DK108357NIDDK NIH HHS R01 DK111175NIDDK NIH HHS R01 DK113984NIDDK NIH HHS R01 DK115875NIGMS NIH HHS R01 GM097194NIH HHS S10 OD025170
6 · The paper itself

Abstract

Lipid droplets (LDs) are distinct and dynamic organelles that affect the health of cells and organs. Much progress has been made in understanding how these structures are formed, how they interact with other cellular organelles, how they are used for storage of triacylglycerol in adipose tissue, and how they regulate lipolysis. Our understanding of the biology of LDs in the heart and vascular tissue is relatively primitive in comparison with LDs in adipose tissue and liver. The National Heart, Lung, and Blood Institute convened a working group to discuss how LDs affect cardiovascular diseases. The goal of the working group was to examine the current state of knowledge on the cell biology of LDs, including current methods to study them in cells and organs and reflect on how LDs influence the development and progression of cardiovascular diseases. This review summarizes the working group discussion and recommendations on research areas ripe for future investigation that will likely improve our understanding of atherosclerosis and heart function.

Indexed as

AnimalsCardiovascular DiseasesConsensus Development Conferences, NIH as TopicDisease Models, AnimalGene-Environment InteractionHumansLipid DropletsLipid MetabolismMyocardiumNational Heart, Lung, and Blood Institute (U.S.)United Statesatherosclerosisheart failuremetabolic syndromeobesitytriglycerides

Identifiers

PMID30012703
PMCPMC6056021
OpenAlexW2886385224

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.